New Vision Pharmaceuticals

We utilize innovative blow-fill-seal (BFS) technology, our flagship single-dose packaging option for liquid and semi-solid products—in addition to traditional packaging. With more than 165,000 square feet of manufacturing site, we are capable of producing in excess of 850 Million doses annually. Our facilities are fully compliant with Good Manufacturing Practices (GMP), and we ensure that FDA regulations are followed and implemented for all products produced in and released from our facility. Our highly automated production lines are designed to deliver Rx, OTC, diagnostic reagents and dietary supplement products, effectively and efficiently. We utilize 24 ISO-certified cleanrooms to ensure a sterile and controlled environment during the manufacturing and packaging processes. As Chief Financial Officer, Carla provides financial leadership for the company, covering accounting, audit, treasury, and corporate finance. Daves educational background is a Bachelor of Science degree in Business Management and Marketing from Minnesota State University Mankato. Prior Experience:22+ years of experience in the pharmaceutical industry, specializing in facilities management, engineering, project management and quality assurance at reputable companies such as CSL Behring, Biotest Pharmaceuticals, and BioTissue Inc..Education: B.S.